Houttuynia cordata Thunb: An Ethnopharmacological Review.
- Wu Z et al (2021).
- Front Pharmacol.
- PubMed:
- 34539401
Studies suggest that compounds from Artemisia annua, a plant historically used to treat malaria, rheumatoid arthritis, and other illnesses, could have anti-severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) properties. In a search for peer-reviewed articles, 19 studies were examined and found that artemisinins demonstrated inhibitory properties against coronavirus-host proteins. The combination of A. annua's biological properties, action on different signaling pathways, and a multi-drug combined-therapy approach may help inhibit SARS-CoV-2 and assist in the treatment of coronavirus disease 2019 (COVID-19).